Vaxart Inc. [VXRT] Is Currently -15.22 below its 200 Period Moving Avg: What Does This Mean?

Related

Vaxart Inc. [NASDAQ: VXRT] stock went on a downward path that fall over -15.22% on Wednesday, amounting to a one-week price decrease of less than -33.25%. The company report on May 9, 2022 that Vaxart Provides Business Update and Reports First Quarter 2022 Financial Results.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .

Sponsored

Data from COVID-19 Phase II study and norovirus Phase IB study are expected in 2022.

Ended the 1st Quarter with $157.0 million in cash, cash equivalents and marketable securities.

Over the last 12 months, VXRT stock dropped by -58.06%. The one-year Vaxart Inc. stock forecast points to a potential upside of 76.47. The average equity rating for VXRT stock is currently 2.00, trading closer to a bullish pattern in the stock market.

The market cap for the stock reached $364.48 million, with 125.48 million shares outstanding and 125.34 million shares in the current float. Compared to the average trading volume of 2.46M shares, VXRT stock reached a trading volume of 3811160 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Guru’s Opinion on Vaxart Inc. [VXRT]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for VXRT shares is $11.60 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on VXRT stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Jefferies have made an estimate for Vaxart Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 29, 2021. While these analysts kept the previous recommendation, Cantor Fitzgerald raised their target price to Overweight. The new note on the price target was released on November 02, 2021, representing the official price target for Vaxart Inc. stock. Previously, the target price had yet another drop from $13 to $9, while B. Riley Securities kept a Neutral rating on VXRT stock.

The Average True Range (ATR) for Vaxart Inc. is set at 0.33, with the Price to Sales ratio for VXRT stock in the period of the last 12 months amounting to 404.98. The Price to Book ratio for the last quarter was 1.83, with the Price to Cash per share for the same quarter was set at 1.25.

VXRT Stock Performance Analysis:

Vaxart Inc. [VXRT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -33.25. With this latest performance, VXRT shares dropped by -41.04% in over the last four-week period, additionally sinking by -59.68% over the last 6 months – not to mention a drop of -58.06% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VXRT stock in for the last two-week period is set at 27.60, with the RSI for the last a single of trading hit 23.36, and the three-weeks RSI is set at 31.21 for Vaxart Inc. [VXRT]. The present Moving Average for the last 50 days of trading for this stock 4.46, while it was recorded at 3.29 for the last single week of trading, and 6.30 for the last 200 days.

Insight into Vaxart Inc. Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and Vaxart Inc. [VXRT] shares currently have an operating margin of -7819.17. Vaxart Inc.’s Net Margin is presently recorded at -7900.22.

Return on Equity for this stock declined to -45.33, with Return on Assets sitting at -37.71.

Vaxart Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 15.70 and a Current Ratio set at 15.70.

Vaxart Inc. [VXRT] Insider Position Details

There are presently around $136 million, or 35.90% of VXRT stock, in the hands of institutional investors. The top three institutional holders of VXRT stocks are: STATE STREET CORP with ownership of 11,187,642, which is approximately 29.594% of the company’s market cap and around 0.30% of the total institutional ownership; BLACKROCK INC., holding 8,452,420 shares of the stock with an approximate value of $27.22 million in VXRT stocks shares; and VANGUARD GROUP INC, currently with $19.27 million in VXRT stock with ownership of nearly -0.026% of the company’s market capitalization.

Positions in Vaxart Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 74 institutional holders increased their position in Vaxart Inc. [NASDAQ:VXRT] by around 7,088,434 shares. Additionally, 59 investors decreased positions by around 1,494,959 shares, while 32 investors held positions by with 33,773,332 shares. The mentioned changes placed institutional holdings at 42,356,725 shares, according to the latest SEC report filing. VXRT stock had 26 new institutional investments in for a total of 900,580 shares, while 19 institutional investors sold positions of 429,643 shares during the same period.